News
The Detroit Lions have tried for two seasons to find a strong pass-rushing complement to Aidan Hutchinson, failing to find lasting success with any of their additions to date. A new report ...
Silence Therapeutics is snatching back two siRNA drug | Silence Therapeutics is snatching back two siRNA drug targets developed through a $20 million collaboration with Mallinckrodt Pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback